5T4 is an oncofetal glycoprotein that is a promising therapeutic target for many cancers, as it is expressed in a wide range of tumor types (including breast, cervical, ovarian, pancreatic, and renal cancers and NSCLC), but shows very limited expression in normal adult tissues (3, 27). Here, TPBG is linked to renal carcinoma.